Literature DB >> 32683738

The outcome of pregnancy in women with cystic fibrosis: a UK population-based descriptive study.

A Ashcroft1, S J Chapman2, L Mackillop1.   

Abstract

OBJECTIVE: To estimate the incidence of cystic fibrosis in pregnancy and to explore obstetric and neonatal outcomes.
DESIGN: A population-based descriptive study using the methodology of the UK Obstetric Surveillance System (UKOSS).
SETTING: All consultant-led maternity units in the UK. POPULATION: All pregnant women with a diagnosis of cystic fibrosis who booked for antenatal care in a UK obstetric unit between March 2015 and February 2017.
METHODS: Prospective case collection identified using UKOSS monthly notification. MAIN OUTCOME MEASURES: Incidence, maternal morbidity, maternal mortality, gestation at delivery, neonatal mortality, neonatal morbidity.
RESULTS: We report 71 pregnancies over a 2-year period. There was one early miscarriage, four terminations and three sets of twins, resulting in the live birth of 69 infants. There were no maternal deaths. One infant died following spontaneous preterm birth at 29 weeks' gestation. The mean gestation at delivery was 36.2 completed weeks. The mean birthweight centile for gestational age was the 61st centile. We report a positive correlation between both maternal lung function (FEV1 ) and mean gestation at delivery, and between FEV1 and mean birthweight centile for gestational age.
CONCLUSIONS: Pregnancy outcomes are generally good in women with cystic fibrosis. Successful pregnancy is possible even in those women with FEV1 <60% predicted, although such women have higher chance of preterm delivery and a smaller baby. TWEETABLE ABSTRACT: Pregnant women with cystic fibrosis who have poorer lung function at the beginning of pregnancy have a higher risk of having a premature or smaller baby.
© 2020 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Cystic fibrosis; pregnancy

Mesh:

Year:  2020        PMID: 32683738     DOI: 10.1111/1471-0528.16423

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

1.  Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design.

Authors:  Raksha Jain; Amalia Magaret; Phuong T Vu; Jill M VanDalfsen; Ashley Keller; Alexandra Wilson; Melissa S Putman; Nicole Mayer-Hamblett; Charles R Esther; Jennifer L Taylor-Cousar
Journal:  BMJ Open Respir Res       Date:  2022-06

Review 2.  Family-building and parenting considerations for people with cystic fibrosis.

Authors:  Traci M Kazmerski; Natalie E West; Raksha Jain; Ahmet Uluer; Anna M Georgiopoulos; Moira L Aitken; Jennifer L Taylor-Cousar
Journal:  Pediatr Pulmonol       Date:  2021-08-18

3.  Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis.

Authors:  Brock Hodges; Zalaya Ivy; Robert M Cronin; Mark Rodeghier; Michael R DeBaun; Shaina M Willen
Journal:  Blood Adv       Date:  2022-03-22

4.  Gestational and pregestational diabetes in pregnant women with cystic fibrosis.

Authors:  Rachael Oxman; Andrea H Roe; Ullal Jagdeesh; Melissa S Putman
Journal:  J Clin Transl Endocrinol       Date:  2021-12-05

Review 5.  Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era.

Authors:  Raksha Jain; Jennifer L Taylor-Cousar
Journal:  J Pers Med       Date:  2021-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.